Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viibryd vs citalopram for depression
CTR20161010Phase 3Active
- Sponsor
- Hengrui Therapeutics
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vilazodone in major depressive disorder (MDD), sponsored by Hengrui Therapeutics. Started Dec 2016; status: active.
02
Drugs
vilazodone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20161010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20161010.